Eaton Vance Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.44M | Sell |
50,324
-100
| -0.2% | -$6.83K | 0.01% | 885 |
|
|
2022
Q2 | $2.28M | Buy |
+50,424
| New | +$2.28M | ﹤0.01% | 1038 |
|
|
2022
Q1 | – | Sell |
-2,025
| Closed | -$96K | – | 1851 |
|
|
2021
Q4 | $96K | Buy |
2,025
+150
| +8% | +$7.11K | ﹤0.01% | 1847 |
|
|
2021
Q3 | $62K | Hold |
1,875
| – | – | ﹤0.01% | 1499 |
|
|
2021
Q2 | $119K | Sell |
1,875
-1,706
| -48% | -$108K | ﹤0.01% | 1828 |
|
|
2021
Q1 | $154K | Buy |
+3,581
| New | +$154K | ﹤0.01% | 1517 |
|